Detailed performance report for NEOGEN CORPORATION covering Q4 2025. Gain clarity on earnings, revenue trends, and AI-enhanced strategic analysis.
Summary of Financial Performance: Neogen reported a return to positive core growth in both segments for the first time in four quarters, with total second-quarter revenues of $224.7 million, up 2.9% on a core basis. The food safety segment generated $165.6 million with core revenue growth of 4.1%, while the animal safety segment had revenues of $59.1 million with flat core revenue growth. Gross margin improved to 47.5%, and adjusted EBITDA was $48.7 million, representing a margin of 21.7%. Adjusted net income and earnings per share were $22.6 million and $0.10, respectively.
Company Outlook & Strategy: The company raised its full-year guidance for fiscal 2026, now expecting revenue between $845 million and $855 million and adjusted EBITDA of approximately $175 million. The strategy focuses on driving top-line growth, operational efficiency, and innovation, with a new leadership team in place to execute these plans.
Key Industry Trends: The company is facing macroeconomic challenges, such as inflationary pressures impacting food production volumes and plant closures in the food industry. There are signs these headwinds may abate as the company transitions into fiscal year 2027.
Operational Highlights: Neogen made significant leadership changes to drive sales culture transformation and operational excellence. The integration of Petrifilm is on track, and improvements in sample collection production efficiency were noted. The company is also divesting its genomics business to focus on debt reduction and margin improvement.
Challenges & Risks: Macroeconomic headwinds, including inflationary pressures and industry disruptions, pose ongoing challenges. The company acknowledges lingering weaknesses in end markets and the need for careful navigation by the new management team.
Key Analyst Questions & Responses: Analysts inquired about the integration of new leadership and its impact on operations. Management emphasized the high caliber of new hires from top-tier diagnostics companies and their immediate contribution to driving growth and operational excellence at Neogen.
Access the official earnings call transcript for NEOGEN-CORPORATION 2025 Q4. It provides valuable insights into management commentary, performance drivers, and forward-looking guidance directly from the company.